Seiji Onogawa
Seiji Onogawa publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment and Gastrointestinal Tumor Research and Treatment.
- World rank
- #2,511,054 of 7,710,434 ranked researchers
- Rank in Japan
- #50,958 of 383,136
- Works
- 42
- Citations
- 687
- Citations per work
- 16.4
What does Seiji Onogawa research?
Seiji Onogawa's work is mostly in Medicine (78%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3378.0%
- Medicine3378.0%
- Everything else716.1%
- Life Sciences25.9%
- 1Surgery20% of their works
- 2Oncology20% of their works
- 3Pulmonary and Respiratory Medicine18% of their works
- 4Gastroenterology14% of their works
- 5Epidemiology7% of their works
- 6Molecular Biology6% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Screening and Detection
- Angiogenesis and VEGF in Cancer
- Neuroendocrine Tumor Research Advances
- Gastrointestinal Bleeding Diagnosis and Treatment
- Colorectal Cancer Surgical Treatments
Which keywords describe Seiji Onogawa's research?
The keywords of their largest research topics: Endoscopic Resection, Survival Analysis, Clinical Practice Guidelines, Chemotherapy, Gastric Cancer, Neoadjuvant Therapy, Preoperative Chemoradiotherapy and Barrett's Esophagus.
- Adjuvant Chemotherapy
- Pancreatic Neuroendocrine Tumors
- Capsule Endoscopy
- VEGF
- Screening
- Colorectal Cancer
- Barrett's Esophagus
- Neoadjuvant Therapy
- Chemotherapy
- Survival Analysis
- Endoscopic Resection
- Clinical Practice Guidelines
- Gastric Cancer
- Preoperative Chemoradiotherapy
- Esophageal Carcinoma
- Imatinib Mesylate
- Sunitinib
- endothelial progenitor cells
- Neuroendocrine Tumors
- Upper Gastrointestinal Bleeding
- Rectal Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Endoscopic Resection232 topics
- Survival Analysis182 topics
- Clinical Practice Guidelines172 topics
- Chemotherapy141 topic
- Gastric Cancer141 topic
- Neoadjuvant Therapy122 topics
- Preoperative Chemoradiotherapy122 topics
- Barrett's Esophagus91 topic
- Esophageal Carcinoma91 topic
- Colorectal Cancer81 topic
- Imatinib Mesylate81 topic
- Screening81 topic
- Sunitinib81 topic
- VEGF51 topic
- endothelial progenitor cells51 topic
- Capsule Endoscopy41 topic
- Neuroendocrine Tumors41 topic
- Pancreatic Neuroendocrine Tumors41 topic
- Upper Gastrointestinal Bleeding41 topic
- Adjuvant Chemotherapy31 topic
- Rectal Cancer31 topic
Where does Seiji Onogawa work?
Seiji Onogawa's main affiliation in the publication record is Onomichi General Hospital, Japan.
How many publications and citations does Seiji Onogawa have?
OpenAlex counts 42 works and 687 citations for Seiji Onogawa, an h-index of 12, ranking #2,511,054 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Seiji Onogawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.